GIANNOULA LAKKA KLEMENT, MD
Medical Practice in Boston, MA
License number
Massachusetts 219313
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
800 Washington St Floating Hospital For Children At Tufts Medical Ctr, Boston, MA 02111
Phone
(617) 636-5535
(617) 636-7738 (Fax)
(617) 536-0515
(617) 562-7142 (Fax)
(617) 636-7738 (Fax)
(617) 536-0515
(617) 562-7142 (Fax)
Personal information
See more information about GIANNOULA LAKKA KLEMENT at radaris.comName
Address
Phone
189 Tappan St, Brookline, MA 02445
45 Hemenway St APT 1, Boston, MA 02115
Boston, MA
45 Hemenway St, Boston, MA 02115
189 Tappan St, Brookline, MA 02445
Professional information
Pediatric Hematology/Oncology Attending At Floating Hospital For Children At Tufts Medical Center
Position:
Assistant Professor at Tufts University, Investigator at Caritas St. Elizabeth's Medical Center/Tufts School of Medicine, Pediatric Hematology/Oncology Attending at Floating Hospital for Children at Tufts Medical Center
Location:
Greater Boston Area
Industry:
Medical Practice
Work:
Tufts University
since May 2009
-
Assistant Professor
Caritas St. Elizabeth's Medical Center/Tufts School of Medicine
since 2009
-
Investigator
Floating Hospital for Children at Tufts Medical Center
since Aug 2009
-
Pediatric Hematology/Oncology Attending
St. Joseph's Medical Center, Toronto
1998 - 2011
-
Attending
Dana-Farber Cancer Institute
Jul 2003 - Jan 2009
-
Pediatric Oncology Attending
Harvard University
2003 - 2009
-
Instructor
Children's Hospital Boston
2003 - 2009
-
Instructor
University of Toronto
1997 - 2002
-
National Cancer Institute of Canada Research Fellow
Education:
McMaster University
University of Toronto
University of Toronto
Giannoula Lakka Klement, Boston MA
Specialties:
Pediatrician
Address:
800 Washington St, Boston, MA 02111
Education:
McMaster University Michael, G. DeGroote School of Medicine - Doctor of Medicine
The Hospital for Sick Children (SickKids) - Fellowship - Pediatric Hematology/Oncology (Pediatrics)
The Hospital for Sick Children (SickKids) - Residency - Pediatrics
The Hospital for Sick Children (SickKids) - Internship - Pediatrics
The Hospital for Sick Children (SickKids) - Fellowship - Pediatric Hematology/Oncology (Pediatrics)
The Hospital for Sick Children (SickKids) - Residency - Pediatrics
The Hospital for Sick Children (SickKids) - Internship - Pediatrics
Board certifications:
American Board of Pediatrics Certification in Pediatrics
Dr. Giannoula L Klement, Boston MA - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
Floating Hospital for Children Hematology/Oncology
800 Washington St SUITE 14, Boston 02111
(617) 636-5535 (Phone), (617) 636-7738 (Fax)
TUFTS MEDICAL CENTER
800 Washington St SUITE 406, Boston 02124
(617) 754-6774 (Phone), (617) 754-6888 (Fax)
800 Washington St SUITE 14, Boston 02111
(617) 636-5535 (Phone), (617) 636-7738 (Fax)
TUFTS MEDICAL CENTER
800 Washington St SUITE 406, Boston 02124
(617) 754-6774 (Phone), (617) 754-6888 (Fax)
Certifications:
Pediatrics, 2006
Awards:
Healthgrades Honor Roll
Languages:
English, Czech
Hospitals:
Floating Hospital for Children Hematology/Oncology
800 Washington St SUITE 14, Boston 02111
TUFTS MEDICAL CENTER
800 Washington St SUITE 406, Boston 02124
Tufts Medical Center
800 Washington Street Pl, Boston 02111
800 Washington St SUITE 14, Boston 02111
TUFTS MEDICAL CENTER
800 Washington St SUITE 406, Boston 02124
Tufts Medical Center
800 Washington Street Pl, Boston 02111
Education:
Medical School
McMaster University / Faculty of Health Sciences
Hospital For Sick Children
Dana-Farber Cancer Institution
Sunnybrook Health Centre
McMaster University / Faculty of Health Sciences
Hospital For Sick Children
Dana-Farber Cancer Institution
Sunnybrook Health Centre
Platelet Biomarkers For Cancer
US Patent:
2009004, Feb 12, 2009
Filed:
Apr 22, 2005
Appl. No.:
11/658377
Inventors:
Judah M. Folkman - Boston MA, US
Giannoula Klement - Boston MA, US
William E. Rich - Redwood Shores CA, US
Vladimir N. Podust - Castro Valley CA, US
Giannoula Klement - Boston MA, US
William E. Rich - Redwood Shores CA, US
Vladimir N. Podust - Castro Valley CA, US
Assignee:
CIPHERGEN BIOSYSTEMS, INC. - Fremont CA
CHILDRENS MEDICAL CENTER CORPORATION - Boston MA
CHILDRENS MEDICAL CENTER CORPORATION - Boston MA
International Classification:
C12Q 1/37, G01N 33/00, G01N 31/22, G01N 33/566
US Classification:
435 23, 436 63, 436501, 422 56, 250282
Abstract:
The present invention relates to the fields of immunology and biochemistry. Particularly, the present invention describes methods, devices and kits for early detection of clinical conditions having associated changes in systemic angiogenic activity, particularly cancers, inflammatory conditions, infections, and events associated with pregnancy and abortion.
Methods And Materials For Treating Burn Injuries
US Patent:
2012015, Jun 21, 2012
Filed:
Nov 22, 2011
Appl. No.:
13/302866
Inventors:
Vaclav Prochazka - Ostrava-Poruba, CZ
Hana Klosova - Studenka, CZ
Giannoula Lakka Klement - Boston MA, US
Hana Klosova - Studenka, CZ
Giannoula Lakka Klement - Boston MA, US
International Classification:
A61F 2/10, A61P 17/00, A61K 35/36
US Classification:
424 9372, 623 2372
Abstract:
This document provides methods and materials involved in treating burn injuries. For example, methods and materials for using skin grafts (e.g., autologous skin grafts) treated with an autologous platelet concentrate and autologous thrombin to treat burn injuries (e.g., deep skin burn injuries) are provided.
Normalization Of Platelet Biomarkers
US Patent:
2013017, Jul 11, 2013
Filed:
Nov 23, 2010
Appl. No.:
13/511168
Inventors:
Jon Peterson - Bellefonte PA, US
Giannoula Klement - Boston MA, US
Joseph Italiano - Brookline MA, US
Sean Downing - Methuen MA, US
Giannoula Klement - Boston MA, US
Joseph Italiano - Brookline MA, US
Sean Downing - Methuen MA, US
Assignee:
THE NEWMAN-LAKKA CANCER FOUNDATION - Scottsdale AZ
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
ORTHO-CLINICAL DIAGNOSTICS, INC. - Rochester NY
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
ORTHO-CLINICAL DIAGNOSTICS, INC. - Rochester NY
International Classification:
G01N 33/68, G01N 33/74
US Classification:
435 792, 4352872
Abstract:
Described herein are methods useful for normalizing any biomarker in platelets. This has application in any method in which one wishes to ascertain or compare the level of a biomarker, e.g., for diagnostic or prognostic methods relating to a biomarker of interest. Using such an approach can permit the assessment of disease status (e.g., angiogenic status) of an individual with less error than an expression value that is not normalized or that is normalized to total protein levels. Also provided are methods for selecting a normalizing protein for normalizing biomarkers in a sample, e.g., a platelet sample.
Platelet Biomarkers For The Detection Of Disease
US Patent:
2013017, Jul 11, 2013
Filed:
Dec 6, 2012
Appl. No.:
13/706483
Inventors:
THE NEWMAN-LAKKA CANCER FOUNDATION - Scottsdale AZ, US
Giannoula Klement - Boston MA, US
Giannoula Klement - Boston MA, US
Assignee:
THE NEWMAN-LAKKA CANCER FOUNDATION - Scottsdale AZ
International Classification:
G01N 33/68
US Classification:
506 9
Abstract:
The present inventors have surprisingly discovered that platelets sequester angiogenic regulators and prevent their degradation. Thus, by analyzing levels of angiogenic regulators in platelets, it is now possible to detect angiogenic activity, even at an early stage. By monitoring for changes in angiogenic activity, the presence of cancer or other angiogenic diseases or disorders can be predicted.
Platelet Biomarkers For The Detection Of Disease
US Patent:
2006020, Sep 14, 2006
Filed:
Apr 26, 2005
Appl. No.:
10/535746
Inventors:
Judah Folkman - Brookline MA, US
Giannoula Klement - Boston MA, US
Giannoula Klement - Boston MA, US
International Classification:
C12Q 1/00, G01N 33/574
US Classification:
435004000, 435007230
Abstract:
The present inventors have surprisingly discovered that platelets sequester angiogenic regulators and prevent their degradation. Thus, by analyzing levels of angiogenic regulators in platelets, it is now possible to detect angiogenic activity, even at an early stage. By monitoring for changes in angiogenic activity, the presence of cancer or other angiogenic diseases or disorders can be predicted.